286 related articles for article (PubMed ID: 26672914)
1. First comparison of adjuvant for trivalent inactivated Haemophilus parasuis serovars 4, 5 and 12 vaccines against Glässer's disease.
Xue Q; Zhao Z; Liu H; Chen K; Xue Y; Wang L
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):153-8. PubMed ID: 26672914
[TBL] [Abstract][Full Text] [Related]
2. Analysis of efficacy obtained with a trivalent inactivated
Zhao Z; Liu H; Xue Y; Chen K; Liu Z; Xue Q; Wang C
Can J Vet Res; 2017 Jan; 81(1):22-27. PubMed ID: 28154458
[TBL] [Abstract][Full Text] [Related]
3. Minimum dose, antigen content, and immunization duration of a trivalent vaccine of inactivated
Zhao Z; Liu H; Zhang K; Xue Q; Chen K; Xue Y
Can J Vet Res; 2016 Oct; 80(4):287-293. PubMed ID: 27733783
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.
Frandoloso R; Martínez S; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Martínez-Fernández B; Gutiérrez-Martín CB
Clin Vaccine Immunol; 2011 Jan; 18(1):50-8. PubMed ID: 20926701
[TBL] [Abstract][Full Text] [Related]
5. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
Hau SJ; Eberle KC; Brockmeier SL
Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
[TBL] [Abstract][Full Text] [Related]
6. Development and antigenic characterization of three recombinant proteins with potential for Glässer's disease prevention.
Li M; Li C; Song S; Kang H; Yang D; Li G
Vaccine; 2016 Apr; 34(19):2251-8. PubMed ID: 26993332
[TBL] [Abstract][Full Text] [Related]
7. Protective Efficacy of an Inactive Vaccine Based on the LY02 Isolate against Acute Haemophilus parasuis Infection in Piglets.
Li XH; Zhao GZ; Qiu LX; Dai AL; Wu WW; Yang XY
Biomed Res Int; 2015; 2015():649878. PubMed ID: 26688815
[TBL] [Abstract][Full Text] [Related]
8. Immune response to oligopeptide permease A (OppA) protein in pigs naturally and experimentally infected with Haemophilus parasuis.
Macedo N; Oliveira S; Torremorell M; Rovira A
Res Vet Sci; 2016 Aug; 107():62-67. PubMed ID: 27473976
[TBL] [Abstract][Full Text] [Related]
9. Sow vaccination modulates the colonization of piglets by Haemophilus parasuis.
Cerdà-Cuéllar M; Naranjo JF; Verge A; Nofrarías M; Cortey M; Olvera A; Segalés J; Aragon V
Vet Microbiol; 2010 Oct; 145(3-4):315-20. PubMed ID: 20447775
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigens.
Álvarez-Estrada Á; Gutiérrez-Martín CB; Rodríguez-Ferri EF; Martínez-Martínez S
BMC Vet Res; 2018 Nov; 14(1):326. PubMed ID: 30400794
[TBL] [Abstract][Full Text] [Related]
11. Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge.
Hu M; Zhang Y; Xie F; Li G; Li J; Si W; Liu S; Hu S; Zhang Z; Shen N; Wang C
Clin Vaccine Immunol; 2013 Jun; 20(6):795-802. PubMed ID: 23536691
[TBL] [Abstract][Full Text] [Related]
12. Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs.
Huang X; Li Y; Fu Y; Ji Y; Lian K; Zheng H; Wei J; Cai X; Zhu Q
Clin Vaccine Immunol; 2013 Jun; 20(6):912-9. PubMed ID: 23616407
[TBL] [Abstract][Full Text] [Related]
13. New insights about functional and cross-reactive properties of antibodies generated against recombinant TbpBs of Haemophilus parasuis.
Barasuol BM; Guizzo JA; Fegan JE; Martínez-Martínez S; Rodríguez-Ferri EF; Gutiérrez-Martín CB; Kreutz LC; Schryvers AB; Frandoloso R
Sci Rep; 2017 Sep; 7(1):10377. PubMed ID: 28871190
[TBL] [Abstract][Full Text] [Related]
14. Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
Zheng X; Yang X; Li X; Qiu GH; Dai A; Huang Q; Huang C; Guo X
Vaccine; 2017 Mar; 35(10):1417-1423. PubMed ID: 28187951
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of glutathione-binding protein A of Haemophilus parasuis as a vaccine candidate in a mouse model.
Zhang Y; Li G; Xie F; Liu S; Wang C
J Vet Med Sci; 2017 Jan; 79(1):184-187. PubMed ID: 27840377
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA).
Olvera A; Pina S; Pérez-Simó M; Aragón V; Segalés J; Bensaid A
Vaccine; 2011 Mar; 29(15):2797-802. PubMed ID: 21320547
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel Haemophilus parasuis serovar 5 vaccine candidates using an immunoproteomic approach.
Li G; Xie F; Li J; Liu J; Li D; Zhang Y; Langford PR; Li Y; Liu S; Wang C
J Proteomics; 2017 Jun; 163():111-117. PubMed ID: 28528009
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5.
Zhou M; Guo Y; Zhao J; Hu Q; Hu Y; Zhang A; Chen H; Jin M
Vaccine; 2009 Aug; 27(38):5271-7. PubMed ID: 19576561
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.
Hau SJ; Luan SL; Loving CL; Nicholson TL; Wang J; Peters SE; Seilly D; Weinert LA; Langford PR; Rycroft AN; Wren BW; Maskell DJ; Tucker AW; Brockmeier SL;
BMC Vet Res; 2020 May; 16(1):167. PubMed ID: 32460764
[TBL] [Abstract][Full Text] [Related]
20. Immunoproteomic analysis of the protective response obtained with subunit and commercial vaccines against Glässer's disease in pigs.
Martínez-Martínez S; Frandoloso R; Rodríguez Ferri EF; Gil C; Hernández-Haro C; Yubero S; Gutiérrez Martín CB
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):235-47. PubMed ID: 23266097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
